But it also works with nontraditional clients, including a cosmetics brand and a company that rents out chairs to hairdressers
Short-acting GLP-1 agonists like exenatide (taken twice daily) may produce more immediate effects on post-meal glucose levels, whilst longer-acting weekly formulations such as semaglutide or dulaglutide provide more sustained action but may take longer to reach steady-state concentrations in the body
Food and Drug Administration, FDA, 8 Nov
Why the Body Sacrifices Hair Under Metabolic Stress Growing hair is metabolically expensive
Ozempic and Wegovy are FDA-approved finished drug products manufactured by Novo Nordisk under FDA oversight and reviewed for safety, effectiveness, and manufacturing quality before reaching patients
However, if weight loss is the main objective, other GLP1 options like Wegovy might provide superior results due to higher dosing for obesity management